Looking to publish in Expert Opinion On Biological Therapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowExpert Opinion on Biological Therapy is a MEDLINE-indexed international hybrid journal focused on biological therapy, including gene therapy, gene transfer technologies, therapeutic peptides and proteins, vaccines and antibodies, cell-based therapies, stem cell therapies, and tissue-based therapies. It publishes rigorously peer-reviewed review articles and original papers, uses double-anonymous peer review after editorial suitability assessment, and does not publish case reports or case series.
Looking to publish in Expert Opinion On Biological Therapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
Expert Opinion On Biological Therapy is an invitation-only journal. Submissions are accepted by invitation from the editorial board only. The following article types are accepted:
Review Articles
Original Research
Drug Evaluation
Clinical Trial Evaluation
Letter To The Editor
Recent Publications
Real-world effectiveness of tezepelumab on clinical remission and small airway dysfunction in severe asthma: a 52-week prospective study
Francesco Menzella, Rory Chan, Marcello Cottini, Michele Mondoni, Elena Parazzini, Laura Ventura, Michela Bortoli, Gianenrico Senna, Carlo Lombardi, Lorenzo Corsi, Andrea Ballarin, Andrea Rastelli, Cristina Albrici, Giulia Carone, Tatiana Scandiuzzi Piovesan, Claudio Sorino, Maria Rita Marchi
Shared challenges in the management of difficult-to-treat chronic inflammatory diseases: expert perspectives
Laure Gossec, Hubert Marotte, Ziad Reguiai, Xavier Hébuterne, Vered Abitbol, Caroline Habauzit, Salim Benkhalifa, Pascal Claudepierre
Monoclonal antibodies in the management of hereditary angioedema
Henriette Farkas, Lili Voloncs-Mindszenthy, Hanga Réka Horváth
An evaluation of telisotuzumab vedotin for the treatment of non-squamous non-small cell lung cancer
Irfan Cicin
Immunotherapy for patients with melanoma in East Asia: current evidence, future directions, and clinical implications
Junjie Gu, Yu Du, Hongwei Fan, Hongfei Li, Jun Guo, Lu Si
Frequently asked questions
How long does it take to publish?
Accepted Author Version is published online in 3 days if the copyright form has been received. Accelerated Publication Plus offers a final decision in as little as 3 weeks, with online publication usually 1-2 weeks after acceptance and first proofs within 5 working days. Accelerated Publication offers a final decision in as little as 9 weeks, with online publication usually 2-3 weeks after acceptance and first proofs within 5 working days.
Reformat to Expert Opinion On Biological Therapy using Livewrite PremiumIs a cover letter required?
A covering letter is required. It must include corresponding author contact details, statements of originality and exclusive submission, confirmation that all authors approved the manuscript and ICMJE conditions were met, ethical approval information, and disclosure of financial or other relationships. Manuscripts without a covering letter or a Disclosure Form are not considered complete submissions.
Reformat to Expert Opinion On Biological Therapy using Livewrite PremiumWhat are the publication costs?
Institutional online-only subscription: USD 9,716.00; institutional print and online subscription: USD 14,201.00.
Reformat to Expert Opinion On Biological Therapy using Livewrite Premium